SPECIAL REPORT
Insights and Opportunities into the State of Precision Oncology in Atlantic Canada Report
Nova Scotia Health
ABSTRACT
This report, prepared by Nova Scotia Health’s Implementation Science Team in partnership with the Atlantic Precision Medicine Initiative, examines the landscape of precision oncology across Atlantic Canada, focusing on foundational aspects that underpin this approach to cancer care. It highlights significant advancements in personalized cancer care, but also highlights regional disparities in testing infrastructure, governance, funding, and workforce capacity, among others. Drawing on findings from national and international literature and local key informant survey and interviews, the report outlines key insights and opportunities for improvement such as potential of unified governance, sustainable funding, and enhanced education and training for clinicians and patients.
Sponsors: Atlantic Precision Medicine Initiative
Lead Scientist: Dr. Mark Embrett
Review Team: Dr. Meaghan Sim, Sophia Salmaniw, Jayden Altman-Prezioso, Dominique Shepard, Amber Jelfs, Marie Elliot, Mohammad Hassani
Citation: Embrett, Mark et al (2025). Insights and Opportunities into the State of Precision Oncology in Atlantic Canada Report. Nova Scotia Health. Canadian Health Policy Journal (CHPJ). APR 2025. ISSN 2562-9492, https://doi.org/10.54194/JSUK6097, canadianhealthpolicy.com.
Review Status: expedited review.
Submitted: 25 FEB 2025 | Published: 09 APR 2025
COPYRIGHT © Canadian Health Policy Institute (CHPI) Inc. All rights reserved.
